Join Lhasa Limited scientists, regulators and industry peers in Natal-RN for three days of practical science, interactive workshops and open discussions. Explore how scientific evidence can support confident safety and quality decisions across pharmaceutical and cosmetics development.
Building on the 2026 symposium, this year’s programme will explore how to assess impurities, establish acceptable limits, understand degradation and apply emerging scientific approaches to regulatory assessments. Through practical case studies and discussions with experts, discover how these approaches can help address real-world challenges and support decision-making.
Why attend?
Put science into practice
Work through realistic cases in interactive workshops led by Lhasa scientists. Test your reasoning, explore different approaches and exchange perspectives with fellow assessors.
Explore regulatory and industry perspectives
Hear how scientists, regulators and industry professionals approach the challenges shaping assessments. Take part in discussions that connect scientific evidence with regulatory expectations and practical decision-making.
Connect insights across industries
Explore the shared challenges facing pharmaceutical and cosmetics safety assessments. Discover where scientific approaches overlap, where different perspectives can add value and how evidence can support decisions across sectors.
Who should attend?
The symposium is designed for toxicologists and safety assessors, regulatory affairs professionals, quality and CMC teams, product development scientists, and cosmetics safety assessors. It will be particularly relevant to those working in impurity qualification, nitrosamines, degradation and pre-formulation, emerging therapeutic modalities and in silico safety assessment.
Whether you generate the evidence, review the assessment or make regulatory decisions, join colleagues and experts to exchange knowledge, challenge assumptions and explore approaches to confident safety assessment.
Join us in Natal
Registration opens soon. Save the date and follow us on LinkedIn for agenda updates and speaker announcements.